Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Claudia Haydeé Saraí Caro-Sánchez"'
Autor:
Giovanny Soca-Chafre, Angelica Montiel-Dávalos, Inti Alberto De La Rosa-Velázquez, Claudia Haydeé Saraí Caro-Sánchez, Adriana Peña-Nieves, Oscar Arrieta
Publikováno v:
International Journal of Genomics, Vol 2019 (2019)
Lung cancer (LC) is the first cause of cancer-related deaths worldwide. Elucidating the pathogenesis of LC will give information on key elements of tumor initiation and development while helping to design novel targeted therapies. LC is an heterogene
Externí odkaz:
https://doaj.org/article/0df7f2bc44d5433cb346c056fcea7ff4
Autor:
Inti A. De La Rosa-Velázquez, Claudia Haydeé Saraí Caro-Sánchez, Oscar Arrieta, Adriana Peña-Nieves, Giovanny Soca-Chafre, Angelica Montiel-Dávalos
Publikováno v:
International Journal of Genomics
International Journal of Genomics, Vol 2019 (2019)
International Journal of Genomics, Vol 2019 (2019)
Lung cancer (LC) is the first cause of cancer-related deaths worldwide. Elucidating the pathogenesis of LC will give information on key elements of tumor initiation and development while helping to design novel targeted therapies. LC is an heterogene
Autor:
Dorian Yarih Garcia-Ortega, MD, MSc, Alethia Alvarez-Cano, MD, Miguel Angel Clara-Altamirano, MD, MSc, Karla Susana Martín-Tellez, MD, Claudia Haydee Sarai Caro-Sánchez, MD, Cuauhtémoc de la Cruz Ruvalcaba-Gonzalez, MD, Hector Martinez-Said, MD, Mario Cuellar-Hubbe, MD, Kuauhyama Luna-Ortiz, MD
Publikováno v:
Cancer Treatment and Research Communications, Vol 26, Iss , Pp 100268- (2021)
Introduction: Lymph node metastasis (LNM) in soft tissue sarcomas (STS) are uncommon, occurring in only 3% – 5% of all sarcomas, and are classified as Stage IV, along with distant metastasis (DM). This paper compares the prognosis of patients with
Externí odkaz:
https://doaj.org/article/9a641f49106c4f288869c0dcdd5fafb5
Autor:
Marco A. Andonegui-Elguera, Yair Alfaro-Mora, Rodrigo Cáceres-Gutiérrez, Claudia Haydee Sarai Caro-Sánchez, Luis A. Herrera, José Díaz-Chávez
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Vasculogenic mimicry (VM) is the formation of vascular channels lacking endothelial cells. These channels are lined by tumor cells with cancer stem cell features, positive for periodic acid-Schiff, and negative for CD31 staining. The term VM was intr
Externí odkaz:
https://doaj.org/article/829a3a5241654ddb8ed418c04d0c423e